The Migraine-Metabolic Connection: Screening for and Addressing Metabolic Syndrome in Patients with Migraine
Abstract
Patients presenting with migraine may benefit from screening for insulin-related comorbidities such as metabolic syndrome. Proper assessment optimizes patient care by simultaneously addressing migraine symptoms and offering therapeutic options that can collectively benefit both conditions and improve not only quality of life but risk factors of cardiovascular disease.
Read the paper
Related studies
- Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines
- A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
- Bioaccessibility and bioavailability of phenolic compounds
- The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
- Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
- Effects of the Mediterranean Diet on the Components of Metabolic Syndrome Concerning the Cardiometabolic Risk
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.